Miramar Capital LLC increased its holdings in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 0.5% during the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 58,978 shares of the financial services provider’s stock after purchasing an additional 272 shares during the period. CME Group accounts for 2.9% of Miramar Capital LLC’s holdings, making the stock its 19th biggest holding. Miramar Capital LLC’s holdings in CME Group were worth $11,595,000 as of its most recent SEC filing.
Several other institutional investors also recently bought and sold shares of CME. Gold Investment Management Ltd. bought a new stake in CME Group during the fourth quarter valued at about $26,000. Salomon & Ludwin LLC purchased a new position in CME Group in the first quarter worth $28,000. Y.D. More Investments Ltd acquired a new position in shares of CME Group during the second quarter worth $36,000. McClarren Financial Advisors Inc. lifted its holdings in shares of CME Group by 66.1% during the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after purchasing an additional 78 shares during the last quarter. Finally, Asset Dedication LLC boosted its position in shares of CME Group by 515.2% in the 2nd quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock worth $40,000 after purchasing an additional 170 shares in the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.
CME Group Trading Down 0.9 %
Shares of CME Group stock opened at $216.30 on Thursday. The stock has a market cap of $77.88 billion, a PE ratio of 24.61, a price-to-earnings-growth ratio of 8.85 and a beta of 0.55. The firm has a fifty day moving average price of $207.08 and a 200 day moving average price of $207.54. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $223.80. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02.
CME Group Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Monday, September 9th will be given a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a yield of 2.13%. The ex-dividend date is Monday, September 9th. CME Group’s dividend payout ratio is currently 52.33%.
Analyst Ratings Changes
CME has been the topic of several recent analyst reports. Piper Sandler reaffirmed an “overweight” rating and set a $225.00 target price on shares of CME Group in a research report on Tuesday, August 20th. Deutsche Bank Aktiengesellschaft upped their price objective on shares of CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a report on Thursday, August 15th. Bank of America cut shares of CME Group from a “neutral” rating to an “underperform” rating and lowered their target price for the stock from $212.00 to $177.00 in a research note on Tuesday, September 3rd. Keefe, Bruyette & Woods upped their price target on shares of CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research note on Thursday, July 25th. Finally, Barclays raised their price target on shares of CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a report on Thursday, July 25th. Four investment analysts have rated the stock with a sell rating, five have given a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $209.73.
Read Our Latest Research Report on CME
Insider Buying and Selling at CME Group
In other news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the transaction, the director now owns 55,607 shares in the company, valued at $11,932,706.13. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the sale, the chief financial officer now owns 13,261 shares in the company, valued at $2,877,504.39. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by corporate insiders.
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Articles
- Five stocks we like better than CME Group
- Manufacturing Stocks Investing
- How Much Can You Make in Stocks in One Month?
- About the Markup Calculator
- This Is the Top Large-Cap Stock Insiders Are Buying
- How to Use the MarketBeat Stock Screener
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.